{
	"type": "relationship",
	"id": "relationship--0465916e-9561-4518-b2fa-09be21bc04e1",
	"created": "2020-09-29T18:40:02.43Z",
	"created_by_ref": "identity--c78cb6e5-0c4b-4611-8297-d1b8b55e40b5",
	"description": "(Citation: CISA WellMail July 2020)(Citation: NCSC APT29 July 2020)(Citation: Cybersecurity Advisory SVR TTP May 2021)",
	"external_references": [
		{
			"description": "CISA. (2020, July 16). MAR-10296782-3.v1 â€“ WELLMAIL. Retrieved September 29, 2020.",
			"source_name": "CISA WellMail July 2020",
			"url": "https://us-cert.cisa.gov/ncas/analysis-reports/ar20-198c"
		},
		{
			"description": "National Cyber Security Centre. (2020, July 16). Advisory: APT29 targets COVID-19 vaccine development. Retrieved September 29, 2020.",
			"source_name": "NCSC APT29 July 2020",
			"url": "https://www.ncsc.gov.uk/files/Advisory-APT29-targets-COVID-19-vaccine-development-V1-1.pdf"
		},
		{
			"description": "NCSC, CISA, FBI, NSA. (2021, May 7). Further TTPs associated with SVR cyber actors. Retrieved July 29, 2021.",
			"source_name": "Cybersecurity Advisory SVR TTP May 2021",
			"url": "https://www.ncsc.gov.uk/files/Advisory-further-TTPs-associated-with-SVR-cyber-actors.pdf"
		}
	],
	"modified": "2021-07-30T18:28:13.04Z",
	"object_marking_refs": [
		"marking-definition--fa42a846-8d90-4e51-bc29-71d5b4802168"
	],
	"relationship_type": "uses",
	"source_ref": "intrusion-set--899ce53f-13a0-479b-a0e4-67d46e241542",
	"spec_version": "",
	"target_ref": "malware--959f3b19-2dc8-48d5-8942-c66813a5101a",
	"x_mitre_attack_spec_version": "",
	"x_mitre_modified_by_ref": "identity--c78cb6e5-0c4b-4611-8297-d1b8b55e40b5",
	"x_mitre_version": "1.0"
}
